Frequency News and Research

RSS

Guidelines for obstetric anesthesia revised

Recognizing that each patient's labor and delivery experience is unique, the American Society of Anesthesiologists (ASA) Practice Guidelines for Obstetric Anesthesia were recently revised to enhance the quality of anesthetic care for obstetric patients, improve patient safety by reducing the incidence and severity of anesthesia-related complications, and increase patient satisfaction.

2 Apr 2007

Multiple genetic risk factors for prostate cancer found

A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) and Harvard Medical School has identified seven genetic risk factors DNA sequences carried by some people but not others that predict risk for prostate cancer.

2 Apr 2007

Radiofrequency (RF) ablation effective for treating inoperable lung cancer

A minimally invasive procedure known as radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery, according to a Rhode Island Hospital study published in the April issue of the journal Radiology.

31 Mar 2007

RF ablation used to treat early-stage, inoperable cancer

Lung cancer patients who are not candidates for surgery now have another safe and effective treatment option: radiofrequency (RF) ablation, according to a new study published in the April issue of the journal Radiology.

31 Mar 2007

Bronchial thermoplasty study

A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.

30 Mar 2007

Medications plus lifestyle changes work as well as angioplasty to reduce deaths in stable heart-disease patients

Coronary revascularization with stenting or balloon angioplasty combined with optimal medical therapy is no more effective in preventing a heart attack, other major cardiovascular events or death in patients with stable heart disease, than optimal medical therapy alone, results of a new study conducted in 50 hospitals in the U.S. and Canada has shown.

27 Mar 2007

Counseling by student-dentists helps patients quit smoking

Students in most dental schools are taught to refer tobacco-using patients they encounter in their clinical training to call a "quit line."

27 Mar 2007

25 per cent of new cases of schizophrenia in the UK may be due to cannabis

If cannabis causes schizophrenia - and that remains in question - then by 2010 up to 25 per cent of new cases of schizophrenia in the UK may be due to cannabis, according to a new study by Dr Matthew Hickman of the University of Bristol and colleagues, published in Addiction journal.

25 Mar 2007

Chronic headache study

Eight out of ten people who took part in a study carried out by a specialist headache centre felt they were much less effective at work and 91 per cent said they felt hampered by headaches on a daily basis, according to the March issue of Cephalalgia.

14 Mar 2007

Arsenic in drinking water can lead to miscarriages and sudden infant death

For the first time, researchers have been able to show that mothers who drink water containing arsenic run an increased risk of having a miscarriage or losing their child in its first year. This has been demonstrated by a research team from Sweden and Bangladesh in an article published last Saturday in the Net edition of American Journal of Epidemiology.

14 Mar 2007

Sedative-hypnotic drugs to get stronger warning labels

The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.

14 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Technologies to improve prevention, tracking and detection of counterfeit medicines

More than twenty technology companies are responding to a call to support the fight against counterfeit medicines spearheaded by the International Medical Products Anti-Counterfeiting Taskforce (IMPACT) set up by the World Health Organization (WHO) and partners.

13 Mar 2007